Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer-Reference-Cited by-同舟云学术

Frequent somatic mutations of the transcription factor ATBF1 in human prostate cancer

Published:2005-03-06 Issue:4 Volume:37 Page:407-412
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Sun Xiaodong,Frierson Henry F,Chen Ceshi,Li Changling,Ran Qimei,Otto Kristen B,Cantarel Brandi M,Vessella Robert L,Gao Allen C,Petros John,Miura Yutaka,Simons Jonathan W,Dong Jin-Tang

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng1528.pdf

Reference29 articles.

1. Knuutila, S. et al. DNA copy number losses in human neoplasms. Am. J. Pathol. 155, 683–694 (1999).

2. Dong, J.T. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev. 20, 173–193 (2002).

3. Nelson, W.G., De Marzo, A.M. & Isaacs, W.B. Prostate cancer. N. Engl. J. Med. 349, 366–381 (2003).

4. Albertson, D.G., Collins, C., McCormick, F. & Gray, J.W. Chromosome aberrations in solid tumors. Nat. Genet. 34, 369–376 (2003).

5. Ninomiya, T. et al. Regulation of the alpha-fetoprotein gene by the isoforms of ATBF1 transcription factor in human hepatoma. Hepatology 35, 82–87 (2002).

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities;Experimental Hematology & Oncology;2024-08-05

2. Tumor evolution analysis uncovered immune-escape related mutations in relapse of diffuse large B-cell lymphoma;Leukemia;2024-07-30

3. ZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated m6A demethylation;Cell Death Discovery;2024-06-13

4. Haploinsufficiency of ZFHX3, encoding a key player in neuronal development, causes syndromic intellectual disability;The American Journal of Human Genetics;2024-03

5. Myeloid Zfhx3 deficiency protects against hypercapnia-induced suppression of host defense against influenza A virus;JCI Insight;2024-01-16